Gut Microbes Affect MicroRNA Response to Bacterial Infection
News Dec 18, 2013
The study reveals that germ-free mice are more susceptible to infection with the foodborne pathogen Listeria monocytogenes than mice with conventional intestinal microbiota.
The authors were also able to show that expression of five intestinal microRNA (miRNA) molecules decreases in conventional mice upon Listeria infection while it did not in germ-free mice, indicating that the gut microbiota may determine, at least in part, how the mouse genome expression is reprogrammed in the gut and how the animal responds to an infection.
"We were surprised by the robustness of the intestinal miRNA signature in germ-free mice and conventional mice," says corresponding author Pascale Cossart of the Institut Pasteur in Paris, France. "Our results show that even very small variations in miRNA expression can have important outcomes," for the health of the animals, says Cossart.
In recent years, researchers have come to recognize that the gut microbiota is an indispensable partner in the development of an animal's immune response and in maintaining its internal stability, but few studies have addressed the impact the microbiota has on miRNA expression during bacterial infections. Cossart and her colleagues approached the matter using the system they know best: Listeria infection. L. monocytogenes is a frequent contaminant of raw milk products, and a highly publicized outbreak traced to Listeria-contaminated cantaloupe left 30 people dead in the fall of 2011.
Previous studies in Cossart’s lab have shown that during infection with Listeria, the bacterium AND the host both reprogram their protein manufacturing using small non-coding RNA molecules like miRNA - pieces of genetic material that are used to selectively regulate the creation of proteins. Here, the researchers used conventional mice and germ-free mice to address the question of whether - and how - the gut microbiota has an effect on the course of infection and on the production of these regulatory miRNA molecules.
When it comes to susceptibility to infection, the results were unequivocal: 24 hours after infection, germ-free mice harbored 10,000 times more L. monocytogenes bacteria in their small intestines and about 1,000 times more Listeria in their mesenteric lymph nodes than did the conventional mice.
At the level of miRNA, however, the differences were not immediately evident: the most highly expressed miRNAs were produced at the same levels in both types of mice and they didn't change much after infection. Nevertheless, the production of five miRNAs decreased after infection only in the conventional mice, indicating that the presence of the microbiota influences the level of miRNA expression.
"We found that even though the intestinal miRNA signature is globally stable, Listeria infection can affect the host miRNA response in a microbiota-dependent manner," says Cossart. When paralleled with the lower susceptibility of the conventional mice to infection, these down-regulated regulatory molecules present an intriguing result, write the authors.
Cossart says that this study and others indicate that miRNA may be involved in protecting the host from infection, but their precise role isn't yet clear. She notes that although this study was conducted in mice, miRNA and the protein coding gene targets they regulate may be very similar in mice and in humans. Cossart and her colleagues are planning to follow up on the work to try and figure out what impacts the changes in miRNA expression mean for the networks of protein-coding genes they regulate.
Study Reveals How MRSA Infection Compromises Lymphatic FunctionNews
Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.
Possible Biomarker to Identify Who Would Benefit from ImmunotherapyNews
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.READ MORE
Fight Against Cancer: Drug Combination Helps Kickstart the Immune SystemNews
Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer.
The breakthrough involves the first ever use of a combination of chemotherapy and a drug being trialled as a treatment for neonatal jaundice, that together help kick start the body's natural defences.